NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Pregabalin and gabapentin ‘should be controlled’

By Mindo - 25th May 2021

Health themes. Background of a large group of assorted capsules, pills and blisters. Drug abuse.

Pregabalin and gabapentin should be made controlled drugs in Ireland, according to the outgoing Medical Council President.

Dr Rita Doyle said addiction to pregabalin – also known by the brand name Lyrica – is “a huge issue” in this country.

“They have now made them controlled drugs in the UK, and I certainly foresee that will happen here,” she said.

In September 2019, the Medical Council warned it would take disciplinary action against doctors in relation to over-prescribing of benzodiazepines, z-drugs, and pregabalin. While the warning was believed to relate to a minority of doctors, a significant number of total complaints involve prescribing practice.

In recent years, regulatory action has been taken against a small number of doctors on this issue. Dr Doyle said the Council’s over-prescribing working group is also discussing prescription of opiates, which became an epidemic in the US.

“And we are a little bit concerned that guidelines need to be more clarified, looking at what are the gold standards in medication and trying to encourage doctors to stick to the gold standards. There is a lot of advertising among the producers of these drugs.”

The Council has collaborated with the HSE, and other bodies, to produce resources for prescribers to raise public awareness of the potential harms associated with benzodiazepines and z-drugs.

These resources were circulated to GPs by the HSE in September 2020, along with a letter from Dr Doyle “to support you in patient consultations regarding benzodiazepines, z-drugs, and pregabalin”.

See news interview, Right-touch regulation – Medical Independent

Leave a Reply

Latest Issue
medical independent 21st November
The Medical Independent 21st November 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read